FAM228B: A Potential Drug Target and Biomarker (G375190)

Target Name: FAM228B

NCBI ID: G375190

FAM228B

Other Name(s): F228B_HUMAN | Protein FAM228B | family with sequence similarity 228 member B | Family with sequence similarity 228, member B | UPF0638 protein B

FAM228B: A Potential Drug Target and Biomarker

FAM228B (F228B_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the family of cytoskeletal proteins known as the myosin regulatory protein (MRP) family, which is responsible for regulating the movement of cells in various tissues.

One of the unique features of FAM228B is its ability to interact with the protein known as F228A, which is also a member of the MRP family. F228A is known to play a role in regulating the assembly and disassembly of other proteins, and it is thought to be involved in the regulation of various cellular processes, including cell division, migration, and survival.

FAM228B is also known to interact with the protein known as p161, which is a known protein that is involved in the regulation of cell growth and apoptosis. p161 is a tumor suppressor protein that is often expressed in cancer cells, and it is thought to play a role in the regulation of cell survival and proliferation.

FAM228B is also expressed in various tissues of the body, including the brain, heart, and kidneys, and it is thought to be involved in the regulation of various cellular processes in these tissues. For example, it is known to play a role in the regulation of neurotransmitter release from neurons, which is important for the function of the brain. It is also thought to be involved in the regulation of blood pressure, as it is expressed in the smooth muscle of the blood vessels.

In addition to its role in cellular processes, FAM228B is also considered a potential drug target or biomarker. Several studies have suggested that FAM228B may be a potential target for small molecule inhibitors, such as drugs that can inhibit its interaction with F228A or p161. These drugs may have the potential to treat various diseases, including cancer, neurodegenerative diseases, and cardiovascular disease.

FAM228B is also a potential biomarker for certain diseases, as its expression has been observed in a variety of disease states, including cancer, neurodegenerative diseases, and cardiovascular disease. For example, it has been shown to be expressed in various types of cancer, including breast, ovarian, and colorectal cancer. It is also thought to be involved in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Overall, FAM228B is a protein that is expressed in various tissues of the human body and is thought to play a role in the regulation of various cellular processes. Its interaction with other proteins, including F228A and p161, makes it a potential target for small molecule inhibitors and a potential biomarker for various diseases. Further research is needed to fully understand its role in cellular processes and its potential as a drug target or biomarker.

Protein Name: Family With Sequence Similarity 228 Member B

The "FAM228B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM228B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets